Table 4 Comparison between iDC and mDC lymph node uptake
From: Evaluation of in vivo labelled dendritic cell migration in cancer patients
Patients | DC i/m × 106 | Isotope | Max uptake (%) * | |
|---|---|---|---|---|
G.C. (no. 1) | i | 6 | 99m Tc-HMPAO | 0.22 |
G.C. (no. 1) | i | 6.9 | 99m Tc-HMPAO | 0.05 |
G.L. (no. 2) | i | 9 | 99m Tc-HMPAO | 0.05 |
P.A.M. (no. 3) | i | 6 | 111 In-Oxine | 0.42 |
T.N. (no. 5) | m | 5.6 | 99m Tc-HMPAO | 1.75 |
P.I.M. (no. 4) | m | 12 | 99m Tc-HMPAO | 0.53 |
PA.M. (no. 3) | m | 7 | 111 In-Oxine | 3.14 |
S.G. (no. 6) | m | 6.4 | 99m Tc-HMPAO | 0.39 |
S.G. (no. 6) | m | 6.7 | 111 In-Oxine | 1.88 |
R.L. (no. 7) | m | 4 | 99m Tc-HMPAO | 0.95 |
G.D. (no. 8) | m | 4 | 99m Tc-HMPAO | 1.02 |